{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T20:34:09Z","timestamp":1769373249437,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,22]]},"DOI":"10.7759\/cureus.102113","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T04:10:20Z","timestamp":1769141420000},"source":"Crossref","is-referenced-by-count":0,"title":["Histopathological Risk Features in Primary and Secondary Enucleation for Group D Retinoblastoma: A Clinicopathological Correlation Study"],"prefix":"10.7759","author":[{"given":"Khawaja Muhammad Ammar Ali","family":"Javed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anum","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Vayani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Hanif","family":"Chatni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.150292","article-title":"The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death","volume":"93","author":"Kivel\u00e4 T","year":"2009","unstructured":"Kivel\u00e4 T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009, 93:1129-31. 10.1136\/bjo.2008.150292","journal-title":"Br J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.6716","article-title":"Global retinoblastoma presentation and analysis by national income level","volume":"6","author":"Fabian ID","year":"2020","unstructured":"Fabian ID, Abdallah E, Abdullahi SU, et al.. Global retinoblastoma presentation and analysis by national income level. JAMA Oncol. 2020, 6:685-95. 10.1001\/jamaoncol.2019.6716","journal-title":"JAMA Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.168062","article-title":"Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators","volume":"94","author":"Canturk S","year":"2010","unstructured":"Canturk S, Qaddoumi I, Khetan V, et al.. Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010, 94:1432-6. 10.1136\/bjo.2009.168062","journal-title":"Br J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61137-9","article-title":"Retinoblastoma","volume":"379","author":"Dimaras H","year":"2012","unstructured":"Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, Gallie BL. Retinoblastoma. Lancet. 2012, 379:1436-46. 10.1016\/S0140-6736(11)61137-9","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Linn Murphree A","year":"2005","unstructured":"Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am. 2005, 18:41-53. 10.1016\/j.ohc.2004.11.003","journal-title":"Ophthalmol Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ohc.2004.11.002","article-title":"Chemotherapy for retinoblastoma","volume":"18","author":"Chan HS","year":"2005","unstructured":"Chan HS, Gallie BL, Munier FL, Beck Popovic M. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am. 2005, 18:55-63. 10.1016\/j.ohc.2004.11.002","journal-title":"Ophthalmol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2012.175","article-title":"Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy","volume":"27","author":"Shields CL","year":"2013","unstructured":"Shields CL, Fulco EM, Arias JD, et al.. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond). 2013, 27:253-64. 10.1038\/eye.2012.175","journal-title":"Eye (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318295f783","article-title":"Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation","volume":"33","author":"Shields CL","year":"2013","unstructured":"Shields CL, Kaliki S, Al-Dahmash S, et al.. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation. Retina. 2013, 33:2103-9. 10.1097\/IAE.0b013e318295f783","journal-title":"Retina"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier FL","year":"2012","unstructured":"Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012, 96:1078-83. 10.1136\/bjophthalmol-2011-301450","journal-title":"Br J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5858\/133.8.1199","article-title":"Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma","volume":"133","author":"Sastre X","year":"2009","unstructured":"Sastre X, Chantada GL, Doz F, et al.. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009, 133:1199-202. 10.5858\/133.8.1199","journal-title":"Arch Pathol Lab Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21067","article-title":"Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma","volume":"49","author":"Chantada GL","year":"2007","unstructured":"Chantada GL, Dunkel IJ, Antoneli CB, et al.. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Pediatr Blood Cancer. 2007, 49:256-60. 10.1002\/pbc.21067","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004250","article-title":"High-risk histopathological features of retinoblastoma following primary enucleation: a global study of 1,426 patients from 5 continents","volume":"44","author":"Kaliki S","year":"2024","unstructured":"Kaliki S, Vempuluru VS, Bakal KR, et al.. High-risk histopathological features of retinoblastoma following primary enucleation: a global study of 1,426 patients from 5 continents. Retina. 2024, 44:2105-15. 10.1097\/IAE.0000000000004250","journal-title":"Retina"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.223","article-title":"Histopathologic observations after intra-arterial chemotherapy for retinoblastoma","volume":"129","author":"Eagle RC Jr","year":"2011","unstructured":"Eagle RC Jr, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol. 2011, 129:1416-21. 10.1001\/archophthalmol.2011.223","journal-title":"Arch Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.3108","article-title":"Treatment of retinoblastoma in 2015: agreement and disagreement","volume":"133","author":"Abramson DH","year":"2015","unstructured":"Abramson DH, Shields CL, Munier FL, Chantada GL. Treatment of retinoblastoma in 2015: agreement and disagreement. JAMA Ophthalmol. 2015, 133:1341-7. 10.1001\/jamaophthalmol.2015.3108","journal-title":"JAMA Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.01.048","article-title":"High-risk histopathology features in primary and secondary enucleated International Intraocular Retinoblastoma Classification Group D eyes","volume":"124","author":"Fabian ID","year":"2017","unstructured":"Fabian ID, Stacey AW, Chowdhury T, et al.. High-risk histopathology features in primary and secondary enucleated International Intraocular Retinoblastoma Classification Group D eyes. Ophthalmology. 2017, 124:851-8. 10.1016\/j.ophtha.2017.01.048","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-306364","article-title":"Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma","volume":"99","author":"Brennan RC","year":"2015","unstructured":"Brennan RC, Qaddoumi I, Billups CA, Free TL, Haik BG, Rodriguez-Galindo C, Wilson MW. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma. Br J Ophthalmol. 2015, 99:1366-71. 10.1136\/bjophthalmol-2014-306364","journal-title":"Br J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23239","article-title":"Clinical predictors of high risk histopathology in retinoblastoma","volume":"58","author":"Kashyap S","year":"2012","unstructured":"Kashyap S, Meel R, Pushker N, et al.. Clinical predictors of high risk histopathology in retinoblastoma. Pediatr Blood Cancer. 2012, 58:356-61. 10.1002\/pbc.23239","journal-title":"Pediatr Blood Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.92151","article-title":"Clinical outcomes of Group D retinoblastoma at a tertiary care hospital in Pakistan","volume":"17","author":"Javed KM","year":"2025","unstructured":"Javed KM, Vayani U, Javed A, Chatni MH. Clinical outcomes of Group D retinoblastoma at a tertiary care hospital in Pakistan. Cureus. 2025, 17:e92151. 10.7759\/cureus.92151","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300498","article-title":"Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results","volume":"96","author":"Abramson DH","year":"2012","unstructured":"Abramson DH, Marr BP, Dunkel IJ, Brodie S, Zabor EC, Driscoll SJ, Gobin YP. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results. Br J Ophthalmol. 2012, 96:499-502. 10.1136\/bjophthalmol-2011-300498","journal-title":"Br J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_3033_24","article-title":"Survival outcomes and globe salvage rates of retinoblastoma in India - a systematic review","volume":"73","author":"Das S","year":"2025","unstructured":"Das S, Mahajan A, Das S, Honavar SG. Survival outcomes and globe salvage rates of retinoblastoma in India - a systematic review. Indian J Ophthalmol. 2025, 73:1116-23. 10.4103\/IJO.IJO_3033_24","journal-title":"Indian J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70045-7","article-title":"Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies","volume":"14","author":"Rushlow DE","year":"2013","unstructured":"Rushlow DE, Mol BM, Kennett JY, et al.. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol. 2013, 14:327-34. 10.1016\/S1470-2045(13)70045-7","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.4097","article-title":"Potential of aqueous humor as a surrogate tumor biopsy for retinoblastoma","volume":"135","author":"Berry JL","year":"2017","unstructured":"Berry JL, Xu L, Murphree AL, et al.. Potential of aqueous humor as a surrogate tumor biopsy for retinoblastoma. JAMA Ophthalmol. 2017, 135:1221-30. 10.1001\/jamaophthalmol.2017.4097","journal-title":"JAMA Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457717-histopathological-risk-features-in-primary-and-secondary-enucleation-for-group-d-retinoblastoma-a-clinicopathological-correlation-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T04:10:26Z","timestamp":1769141426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457717-histopathological-risk-features-in-primary-and-secondary-enucleation-for-group-d-retinoblastoma-a-clinicopathological-correlation-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.102113","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,22]]}}}